Vitamin D3 for Life

Live Enlightened

Research libraryVitamin D3 For Life
Study design and methods

Primary relevance to vitamin D Vitamin D is a stated subject of this paper.

Vitamin D is a stated subject of this paper; the supporting source evidence is shown below.

Why this paper is included

Supporting source evidence:

Using univariate between‐group analyses, vitamin D deficiency was associated with higher body weight and lower calcium plasma levels at T0, as well as increased craving intensity for both the substance at the origin of the treatment and food at T1.

Source: Abstract. View original paper

Relevance classification does not establish study quality, causation or editorial approval.

Study design Study design awaiting verification.

Study design awaiting verification

The available source does not establish a sufficiently clear study design.

Meta-analysis unclear · Blinding unclear / not reported · Research setting awaiting verification

How this paper was classified

Automatic source-based classification; awaiting editorial verification. This is not a quality score.

View supporting evidence in the original paper

What the study types mean
Systematic review
Uses explicit methods to identify, assess and summarise research on a defined question.
Scoping review
Maps the extent and characteristics of research on a topic.
Narrative review
Discusses existing research; systematic-review methods have not been established by this classification.
Review / evidence synthesis
Reviews existing research; the exact review methods need further assessment.
Randomised controlled trial
Assigns participants or groups to comparison interventions by chance.
Non-randomised intervention study
Examines an intervention without random allocation.
Cohort study
Examines exposures and outcomes over time within a defined group.
Case-control study
Compares people with an outcome against people without it, examining exposures.
Cross-sectional study
Examines a population at a particular point in time.
Observational study
Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
Case report
Describes an individual case.
Case series
Describes a group of individual cases.
Secondary analysis
Analyses existing study data; this paper is not automatically another independent trial.
Laboratory study
Investigates biological processes in a laboratory setting.
Qualitative study
Examines experiences or meanings using qualitative methods.
Genetic instrumental-variable study
Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
Study protocol
Describes planned methods and is not evidence that the planned study has reported results.
Multiple reported designs
More than one design is explicitly reported; examine the supporting methods.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.

Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.

Abstracts

Associations Between Vitamin D Status and Clinical Presentation Among French Inpatients With Substance Use Disorders

Study design awaiting verification · Addiction Biology · 2026

Original publication title

Associations Between Vitamin D Status and Clinical Presentation Among French Inpatients With Substance Use Disorders

Luca Pavirani; Bibi Aliya Seelarbokus; Léa Marinelli; Pauline Desnavailles; Sylvie Berthoz; Melina Fatseas

© 2026 The Author(s). Addiction Biology published by John Wiley & Sons Ltd on behalf of Society for the Study of Addiction.

Original publication · Publisher record · CC BY 4.0

Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.

Authors’ conclusion

This study confirms the high prevalence of vitamin D deficiency among inpatients treated for SUDs. Although preliminary, our findings highlight the importance of assessing vitamin D levels in SUDs. They call for further research on its role in relapse vulnerability and the potential benefits of its supplementation during drug withdrawal treatment.

An extract from the source publication. Read it in context.

At a glance

Abstract: What objectives does the paper state?

This study aims to explore among inpatients treated for various types of SUDs differences in addiction‐related, psychopathological and biological characteristics based on vitamin D status.

Source: Objective

Abstract: What methods does the paper describe?

The sample included 260 participants hospitalized in a French addiction treatment unit. Vitamin D concentration and other biomarkers, SUDs severity and other psychiatric disorders, cognitive functioning and impulsivity were collected at hospital admission (T0). Perceived negative affectivity and craving (for the main substance and food) were collected at T0 and hospital discharge (T1).

Source: Methods

Abstract: Results

About 89.3% of the participants had a vitamin D deficiency as defined by French recommendations (< 30 ng/mL). Using univariate between‐group analyses, vitamin D deficiency was associated with higher body weight and lower calcium plasma levels at T0, as well as increased craving intensity for both the substance at the origin of the treatment and food at T1. Multivariate regression analyses showed no significant associations between vitamin D or calcium levels and craving intensities at T1.

Source: Results

Abstract: Conclusion

This study confirms the high prevalence of vitamin D deficiency among inpatients treated for SUDs. Although preliminary, our findings highlight the importance of assessing vitamin D levels in SUDs. They call for further research on its role in relapse vulnerability and the potential benefits of its supplementation during drug withdrawal treatment.

Source: Conclusion
Authors’ abstract

ABSTRACT

Background

Numerous studies have demonstrated that vitamin D plays a crucial role in modulating dopaminergic pathways, suggesting a potential role in the pathophysiology of addictive disorders. However, among individuals with substance use disorders (SUDs), the link between vitamin D and addiction‐related symptoms has not been sufficiently studied.

Objective

This study aims to explore among inpatients treated for various types of SUDs differences in addiction‐related, psychopathological and biological characteristics based on vitamin D status.

Methods

The sample included 260 participants hospitalized in a French addiction treatment unit. Vitamin D concentration and other biomarkers, SUDs severity and other psychiatric disorders, cognitive functioning and impulsivity were collected at hospital admission (T0). Perceived negative affectivity and craving (for the main substance and food) were collected at T0 and hospital discharge (T1).

Results

About 89.3% of the participants had a vitamin D deficiency as defined by French recommendations (< 30 ng/mL). Using univariate between‐group analyses, vitamin D deficiency was associated with higher body weight and lower calcium plasma levels at T0, as well as increased craving intensity for both the substance at the origin of the treatment and food at T1. Multivariate regression analyses showed no significant associations between vitamin D or calcium levels and craving intensities at T1.

Conclusion

This study confirms the high prevalence of vitamin D deficiency among inpatients treated for SUDs. Although preliminary, our findings highlight the importance of assessing vitamin D levels in SUDs. They call for further research on its role in relapse vulnerability and the potential benefits of its supplementation during drug withdrawal treatment.

Publication and source details

Original title: Associations Between Vitamin D Status and Clinical Presentation Among French Inpatients With Substance Use Disorders

Luca Pavirani; Bibi Aliya Seelarbokus; Léa Marinelli; Pauline Desnavailles; Sylvie Berthoz; Melina Fatseas

Addiction Biology · 2026

* Correspondence:
Sylvie Berthoz (sylvie.berthoz-landron@inserm.fr)
© 2026 The Author(s). Addiction Biology published by John Wiley & Sons Ltd on behalf of Society for the Study of Addiction.https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.

Repository JATS snapshot; version as supplied

Source retrieved: 2026-11-11T00:30:30.625264+00:00

DOI: 10.1111/adb.70110 · PMC12780537